New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Government's Anti-Cyber Fraud Drive Disconnects 39.4 Lakh Mobile Connections, Blacklists 2.27 Lakh Handsets
IND Vs ENG, U19 WC Final: Vaibhav Suryavanshi Smashes These Records After Mind-Boggling 175 Off 80 Balls
Crompton Q3 Profit Falls 9.8% To ₹101 Crore, Revenue Rises 7.3% To ₹1,898 Crore & Beats Estimates
Airtel Q3 FY26 Net Profit Falls 55% YoY Amid High Base Effect, Revenue Grows Steadily
